Ionis Pharmaceuticals Inc (IONS)
41.84
+0.77
(+1.87%)
USD |
NASDAQ |
Apr 23, 16:00
41.84
0.00 (0.00%)
After-Hours: 17:58
Ionis Pharmaceuticals Market Cap: 6.098B for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 5.986B |
| April 19, 2024 | 5.929B |
| April 18, 2024 | 5.948B |
| April 17, 2024 | 5.963B |
| April 16, 2024 | 6.055B |
| April 15, 2024 | 6.056B |
| April 12, 2024 | 6.084B |
| April 11, 2024 | 6.194B |
| April 10, 2024 | 6.259B |
| April 09, 2024 | 6.243B |
| April 08, 2024 | 6.157B |
| April 05, 2024 | 6.299B |
| April 04, 2024 | 6.243B |
| April 03, 2024 | 6.381B |
| April 02, 2024 | 6.267B |
| April 01, 2024 | 6.404B |
| March 28, 2024 | 6.318B |
| March 27, 2024 | 6.509B |
| March 26, 2024 | 6.429B |
| March 25, 2024 | 6.400B |
| March 22, 2024 | 6.227B |
| March 21, 2024 | 6.231B |
| March 20, 2024 | 6.235B |
| March 19, 2024 | 6.145B |
| March 18, 2024 | 6.126B |
| Date | Value |
|---|---|
| March 15, 2024 | 6.202B |
| March 14, 2024 | 6.148B |
| March 13, 2024 | 6.291B |
| March 12, 2024 | 6.292B |
| March 11, 2024 | 6.305B |
| March 08, 2024 | 6.412B |
| March 07, 2024 | 6.511B |
| March 06, 2024 | 6.455B |
| March 05, 2024 | 6.441B |
| March 04, 2024 | 6.540B |
| March 01, 2024 | 6.626B |
| February 29, 2024 | 6.589B |
| February 28, 2024 | 6.783B |
| February 27, 2024 | 6.910B |
| February 26, 2024 | 6.719B |
| February 23, 2024 | 6.611B |
| February 22, 2024 | 6.410B |
| February 21, 2024 | 6.345B |
| February 20, 2024 | 6.464B |
| February 16, 2024 | 6.476B |
| February 15, 2024 | 6.600B |
| February 14, 2024 | 7.083B |
| February 13, 2024 | 7.016B |
| February 12, 2024 | 7.272B |
| February 09, 2024 | 7.419B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.616B
Minimum
Dec 01 2021
10.48B
Maximum
Apr 23 2019
6.604B
Average
6.317B
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals Inc | 4.342B |
| Viking Therapeutics Inc | 6.527B |
| Alnylam Pharmaceuticals Inc | 18.39B |
| Akero Therapeutics Inc | 1.449B |
| 89bio Inc | 849.40M |
Market Cap Related Metrics
| PS Ratio | 7.606 |
| PEG Ratio | -0.4705 |
| Price to Book Value | 15.77 |
| Price | 41.84 |
| Earnings Yield | -6.12% |
| PEGY Ratio | -0.4705 |